About Genomic Solutions
Genomic Solutions is a company based in Ann Arbor (United States) founded in 1997 was acquired by Harvard Bioscience in July 2002. Genomic Solutions operates in a competitive market with competitors including Abcam, Stem Cell Technologies, Parse Biosciences, Biofidelity and RareCyte, among others.
- Headquarter Ann Arbor, United States
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website genomicsolutions.com
- Social LinkedIn
- Acquired by Harvard Bioscience (Jul 2002)
- Investors
- Acquired byHarvard Bioscience
(Jul 2002)
Investors in Genomic Solutions
Genomic Solutions has secured backing from 1 investor. Prominent investors backing the company include Harvard Bioscience.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life science equipment and instruments are manufactured and supplied. | 1901 | harvardbioscience.com | Holliston, United States |
Investor details for Genomic Solutions
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Genomic Solutions
3 dated milestones of Genomic Solutions across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Genomic Solutions is founded.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Harvard Bioscience.
Competitors of Genomic Solutions
Genomic Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, Parse Biosciences, Biofidelity and RareCyte, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| parsebiosciences.com | 2018 | Seattle, United States | $100.26M | – | RNA-sequencing transcriptome kits for health data analysis are developed. | |
| biofidelity.com | 2002 | Cambridge, United Kingdom | $59.91M | 28 | Molecular diagnostic assays are developed for target DNA sequence detection. | |
| rarecyte.com | 2009 | Seattle, United States | $114.33M | 54 | Developer of technologies for the analysis of rare and single cells in the blood | |
| qiagen.com | 1984 | Hilden, Germany | – | 104 | Products and reagents for molecular diagnostic assays are supplied. | |
| raindancetech.com | 2004 | Billerica, United States | $111.66M | 105 | Developer of nucleic acid detection and quantification systems | |
| sebia.com | 1967 | Evry Courcouronnes, France | – | – | Electrophoresis-based in vitro diagnostics products are developed and provided. | |
| nuprobe.com | 2016 | George Town, Cayman Islands | $61M | – | Sensitive multiplex platforms for QPCR are developed using toehold probes. |
Detailed competitors of Genomic Solutions
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Genomic Solutions
10 companies that operate in the same segment as Genomic Solutions (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Genomic Solutions
Genomic Solutions was founded in 1997.
Genomic Solutions is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Genomic Solutions Inc. designs, develops, and manufactures genomic and proteomic instrumentation, software, consumables, and services. The company offers cell based assays, arrayingplate printing products, micromacro protein array products, drug discovery products, assay assembly products, DNARNA synthesis products, and sequencing products. The company also provides instruments, such as gene machines, proteomic systems, and dispensing systems, as well as HT Analyzer and HT Analyzer evolution software. In addition, it offers consumables and OEM parts. The company was formerly known as Bio-Image Corp. and changed its name to Genomic Solutions Inc. in 1998. The company was founded in 1997 and is based in Ann Arbor, Michigan. As of November 30, 2007, Genomic Solutions Inc. operates as a subsidiary of Digilab, Inc.
Genomic Solutions's top competitors include Abcam, Qiagen and Parse Biosciences.
Genomic Solutions has 1 investor. Key investors include Harvard Bioscience.
Yes. Genomic Solutions was acquired by Harvard Bioscience in July 2002.